心脏淀粉样变性心肌细胞外容积定量:心脏CT与磁共振成像的对比研究
该回顾性研究纳入31例心脏淀粉样变性患者,同时行心脏CT与心脏磁共振(CMR)检查,以CMR-ECV为参考标准评估CT-ECV的一致性。结果显示CT与CMR的全局ECV均值无显著差异(51.3%±10.2% vs 50.0%±10.5%),各节段及全局CT-ECV与CMR-ECV均显著相关(r=0.77~0.88),且ECV与临床参数相关。作者认为CT-ECV可作为CMR-ECV的影像生物标志物和替代方法。
要点
- 心脏淀粉样变性患者中,CT与CMR测得的全局ECV均值无显著差异(51.3%±10.2% vs 50.0%±10.5%)。
- CT-ECV与CMR-ECV在室间隔、侧壁、下壁、前壁及全局均显著相关(r=0.77~0.88)。
- CT-ECV与临床参数显著相关,作者认为其可作为CMR-ECV的影像生物标志物和替代方法。
核心结论
- 心脏CT可定量心肌ECV,在心脏淀粉样变性患者中获得与CMR可比的结果,且CT-ECV与临床参数显著相关,因此CT-ECV可作为影像生物标志物和CMR-ECV的替代方法。
研究设计与样本
- 回顾性研究,纳入31例同时接受心脏CT和CMR检查的心脏淀粉样变性患者,以CMR-ECV为参考标准,采用Pearson相关分析评估各节段CT-ECV与CMR-ECV的相关性,并评估ECV与临床参数的相关性。
诊断标准与关键数值
- CT与CMR的全局ECV均值无显著差异(51.3%±10.2% vs 50.0%±10.5%)。
- CT-ECV与CMR-ECV的相关系数:室间隔r=0.88,侧壁r=0.80,下壁r=0.79,前壁r=0.77,全局r=0.87。
临床应用与阅片要点
- 在心脏淀粉样变性患者中,CT-ECV与CMR-ECV在全局及各节段均显著相关,CT-ECV可作为CMR-ECV的替代方法。
- CT和CMR中,ECV与高敏心肌肌钙蛋白T水平呈弱至强相关,与整体纵向应变呈中度相关,与左心室射血分数呈负相关。
- 室间隔ECV和全局ECV与临床参数的相关性略高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Myocardial extracellular volume (ECV) on computed tomography (CT), an alternative to cardiac magnetic resonance (CMR), has significant practical clinical advantages. However, the consistency between ECVs quantified via CT and CMR in cardiac amyloidosis (CA) has not been investigated sufficiently. Therefore, the current study investigated the application of CT-ECV in CA with CMR-ECV as the reference standard.
METHODS: We retrospectively evaluated 31 patients with CA who underwent cardiac CT and CMR. Pearson correlation analysis was performed to investigate correlations between CT-ECV and CMR-ECV at each segment. Further, correlations between ECV and clinical parameters were assessed.
RESULTS: There were no significant differences in the mean global ECVs between CT scan and CMR (51.3% ± 10.2% vs 50.0% ± 10.5%). CT-ECV was correlated with CMR-ECV at the septal (r = 0.88), lateral (r = 0.80), inferior (r = 0.79), anterior (r = 0.77) segments, and global (r = 0.87). In both CT and CMR, the ECV had a weak to strong correlation with high-sensitivity cardiac troponin T level, a moderate correlation with global longitudinal strain, and an inverse correlation with left ventricular ejection fraction. Further, the septal ECV and global ECV had a slightly higher correlation with the clinical parameters.
CONCLUSIONS: Cardiac CT can quantify myocardial ECV and yield results comparable to CMR in patients with CA. Moreover, a significant correlation between CT-ECV and clinical parameters was observed. Thus, CT-ECV can be an imaging biomarker and alternative to CMR-ECV.
CLINICAL RELEVANCE STATEMENT: Cardiac CT can quantify myocardial ECV and yield results comparable to CMR in patients with CA, and CT-ECV can be used clinically as an imaging biomarker and alternative to CMR-ECV.
KEY POINTS: • A significant correlation was found between CT myocardial extracellular volume and cardiac MR myocardial extracellular volume in patients with cardiac amyloidosis. • In CT and cardiac MR, the myocardial extracellular volume correlated well with high-sensitivity cardiac troponin T level, global longitudinal strain, and left ventricular ejection fraction. • CT myocardial extracellular volume can be an imaging biomarker and alternative to cardiac MR myocardial extracellular volume.
引用
- Hayashi H, Oda S, Kidoh M, et al. Myocardial extracellular volume quantification in cardiac amyloidosis: a comparative study between cardiac computed tomography and magnetic resonance imaging. Eur Radiol. 2023. PMID: 37597032. doi:10.1007/s00330-023-10129-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。